Brief: Herantis Pharma may issue maximum of 800,000 shares
Nov 9 (Reuters) - HERANTIS PHARMA OYJ HRTIS.HE :
* MAXIMUM OF 800,000 SHARES MAY BE ISSUED
* SHARES MAY BE ISSUED, AMONG OTHERS, FOR PURPOSES OF
FINANCING
LYMFACTIN CLINICAL STUDIES
Source text for Eikon: ID:nGNEc1jkJt
Further company coverage: HRTIS.HE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))